{{cart_num}}
My CartCAS：239480-61-6
Molecular Formula：C66H112N20O21
Molecular Weight：1521.7
Purity：≥95%
Appearance：Lyophilized powder
Storage：Store at -20℃，2 years.(Avoid freeze/thaw cycles)
Qty：
Size：
| Product Type | Peptides |
| CAS | 239480-61-6 |
| Sequence(1LC) | SHLVEALALVAGERG |
| Sequence(3LC) | Ser-His-Leu-Val-Glu-Ala-Leu-Ala-Leu-Val-Ala-Gly-Glu-Arg-Gly |
| Molecular Formula | C66H112N20O21 |
| Molecular Weight | 1521.7 |
| Purity | ≥95% |
| Appearance | Lyophilized powder |
| Salt Form | Trifluoroacetate salt |
| Source | Synthetic |
| Storage | Store at -20℃，2 years.(Avoid freeze/thaw cycles) |
| Category/Label | Inflammation Research |
| Background | NBI-6024， an altered peptide ligand (APL)， is an epitope recognized by inflammatory interferon-gamma-producing T helper lymphocytes in type 1 diabetic patients. |
| Reference | [1]. D G Alleva et al. Immunomodulation in type 1 diabetes by NBI-6024， an altered peptide ligand of the insulin B epitope. Scand J Immunol. 2006 Jan;63(1):59-69. [2]. Alleva DG， et al. Immunological characterization and therapeutic activity of an altered-peptide ligand， NBI-6024， based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes. 2002 Jul;51(7):2126-34. |
| Unit | Bottle |
| Specification | 1mg 5mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
